首页> 外文期刊>Pharmacoepidemiology and drug safety >Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
【24h】

Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.

机译:初级保健教育干预措施后降压药物利用变化的测量。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To measure changes in drug utilisation following a national general practice education program aimed at improving prescribing for hypertension. METHODS: A series of nationally implemented, multifaceted educational interventions using social marketing principles focusing on prescribing for hypertension, was commenced in October 1999, and repeated in September 2001 and August 2003. The target group was all primary care prescribers in Australia and interventions were both active (voluntary) and passive. Newsletter and prescribing feedback was mailed in October 1999, September 2001 (newsletter only) and August 2003. Approximately a third of general practitioners (GPs) in Australia undertook at least one active educational activity (clinical audit, educational visit or case study) during the period October 1999-April 2004. National dispensing data from 1996 to 2004 were analysed using time series methodology with a decay term for intervention effect, to assess trends in prescribing of various classes of antihypertensives. In particular, the program aimed to increase the prescribing of thiazide diuretics and beta blockers. RESULTS: Consistent with key intervention messages, the program achieved an increase in low-dose thiazide and beta blocker prescribing. The rate of prescribing of low-dose thiazides doubled from 1.1 per 1000 consultations in October 1999 to 2.4 per 1000 in October 2003. Beta-blocker utilisation showed a more modest but significant increase over the time of the study, with the change in observed versus expected rate of prescribing increasing by 8% by April 2004. Therapeutic options for treating hypertension changed markedly in the time of the study with the advent of ACE inhibitor/Angiotensin II receptor antagonists and thiazide combination products. It is important, therefore, to interpret the results in light of these changes. CONCLUSION: A national education program aimed at GPs was successful in improving prescribing for hypertension. Lessons learned will be applied in evaluation of future NPS programs and are also applicable to analysis of other interventions aimed at influencing prescribing behaviour.
机译:目的:根据一项旨在改善高血压处方的全国通用实践教育计划,测量药物使用的变化。方法:从1999年10月开始,在全国范围内实施了一系列针对社会的营销干预措施,采用了注重高血压处方的社会营销原则,并于2001年9月和2003年8月重复进行。目标人群是澳大利亚的所有初级保健处方者,干预措施均为主动(自愿)和被动。在1999年10月,2001年9月(仅新闻通讯)和2003年8月邮寄了时事通讯和处方反馈。在此期间,澳大利亚约有三分之一的全科医生从事了至少一项积极的教育活动(临床审核,教育访问或案例研究)。期间为1999年10月至2004年4月。采用时间序列方法分析了干预效果的衰减项,分析了1996年至2004年的全国分配数据,以评估各种降压药处方的趋势。特别是,该计划旨在增加对噻嗪类利尿剂和β受体阻滞剂的处方。结果:与关键的干预信息相一致,该计划在低剂量噻嗪类和β受体阻滞剂的处方上有所增加。低剂量噻嗪类药物的开处方率从1999年10月的每1000例诊疗中的1.1倍增至2003年10月的每1000例诊疗中2.4例。在研究期间,β受体阻滞剂的使用显示出较温和但显着的增加,观察到的变化与预期到2004年4月开处方率将增加8%。随着ACE抑制剂/血管紧张素II受体拮抗剂和噻嗪类联合产品的问世,用于治疗高血压的治疗选择发生了明显变化。因此,重要的是要根据这些变化来解释结果。结论:针对全科医生的国家教育计划在改善高血压处方方面取得了成功。所汲取的经验教训将用于评估未来的NPS计划,也可用于分析其他旨在影响处方行为的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号